S&P 100
3.553,60
PKT
-17,76
PKT
-0,50
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu S&P 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.01.12 | Microsoft buy | Nomura | |
| 11.01.12 | PepsiCo neutral | UBS AG | |
| 11.01.12 | Coca-Cola neutral | UBS AG | |
| 11.01.12 | QUALCOMM outperform | Oppenheimer & Co. Inc. | |
| 11.01.12 | Walmart sector perform | Scotia Capital Markets | |
| 11.01.12 | Citigroup overweight | Barclays Capital | |
| 11.01.12 | Walt Disney equal-weight | Barclays Capital | |
| 11.01.12 | Bank of America equal-weight | Barclays Capital | |
| 11.01.12 | Capital One Financial overweight | Barclays Capital | |
| 11.01.12 | Wells Fargo overweight | Barclays Capital | |
| 11.01.12 | JPMorgan Chase overweight | Barclays Capital | |
| 11.01.12 | Intel halten | Hamburger Sparkasse AG (Haspa) | |
| 11.01.12 | Bank of New York Mellon overweight | Barclays Capital | |
| 11.01.12 | U.S. Bancorp overweight | Barclays Capital | |
| 11.01.12 | Merck hold | Jefferies & Company Inc. | |
| 10.01.12 | Linde buy | Sarasin Research | |
| 10.01.12 | Pfizer buy | Goldman Sachs Group Inc. | |
| 10.01.12 | Bristol-Myers Squibb overweight | Barclays Capital | |
| 10.01.12 | Pfizer verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 10.01.12 | Amazon equal-weight | Barclays Capital | |
| 10.01.12 | Linde buy | Société Générale Group S.A. (SG) | |
| 10.01.12 | Eli Lilly hold | Jefferies & Company Inc. | |
| 10.01.12 | ExxonMobil buy | Goldman Sachs Group Inc. | |
| 10.01.12 | Amgen outperform | Sanford C. Bernstein and Co., Inc. | |
| 09.01.12 | Boeing neutral | UBS AG | |
| 09.01.12 | Linde buy | Deutsche Bank AG | |
| 09.01.12 | ExxonMobil outperform | Macquarie Research | |
| 09.01.12 | Verizon neutral | Nomura | |
| 09.01.12 | AT&T buy | Nomura | |
| 09.01.12 | Bank of America overweight | JP Morgan Chase & Co. | |
| 09.01.12 | Visa buy | Nomura | |
| 09.01.12 | Citigroup buy | Nomura | |
| 09.01.12 | Citigroup overweight | JP Morgan Chase & Co. | |
| 09.01.12 | Pfizer outperform | Sanford C. Bernstein and Co., Inc. | |
| 09.01.12 | Gilead Sciences buy | Needham & Company, LLC | |
| 09.01.12 | Boeing buy | Citigroup Corp. | |
| 09.01.12 | Starbucks buy | Jefferies & Company Inc. | |
| 09.01.12 | Bank of America buy | Citigroup Corp. | |
| 09.01.12 | Chevron outperform | Macquarie Research | |
| 09.01.12 | Boeing overweight | JP Morgan Chase & Co. |